PCI Biotech (Norway) Price on August 23, 2024
PCIB Stock | NOK 1.50 0.05 3.45% |
If you're considering investing in PCI Stock, it is important to understand the factors that can impact its price. As of today, the current price of PCI Biotech stands at 1.50, as last reported on the 2nd of December, with the highest price reaching 1.50 and the lowest price hitting 1.40 during the day. PCI Biotech Holding maintains Sharpe Ratio (i.e., Efficiency) of -0.0139, which implies the company had a -0.0139% return per unit of volatility over the last 3 months. PCI Biotech Holding exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PCI Biotech's market risk adjusted performance of (0.30), and Variance of 48.43 to confirm the risk estimate we provide.
PCI Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
PCI |
Sharpe Ratio = -0.0139
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PCIB |
Estimated Market Risk
6.87 actual daily | 61 61% of assets are less volatile |
Expected Return
-0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PCI Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PCI Biotech by adding PCI Biotech to a well-diversified portfolio.
PCI Biotech Valuation on August 23, 2024
It is possible to determine the worth of PCI Biotech on a given historical date. On August 23, 2024 PCI was worth 1.75 at the beginning of the trading date compared to the closed value of 1.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PCI Biotech stock. Still, in general, we apply an absolute valuation method to find PCI Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PCI Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PCI Biotech's related companies.
Open | High | Low | Close | Volume | |
1.80 | 1.89 | 1.75 | 1.75 | 97,776 | |
08/23/2024 | 1.75 | 1.80 | 1.75 | 1.76 | 13,461 |
1.75 | 1.80 | 1.72 | 1.72 | 85,951 |
Backtest PCI Biotech | | | PCI Biotech History | | | PCI Biotech Valuation | Previous | Next |
PCI Biotech Trading Date Momentum on August 23, 2024
On August 26 2024 PCI Biotech Holding was traded for 1.72 at the closing time. The highest price during the trading period was 1.80 and the lowest recorded bid was listed for 1.72 . The volume for the day was 86 K. This history from August 26, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 2.27% . The trading delta at closing time to the current price is 7.39% . |
PCI Biotech Holding Fundamentals Correlations and Trends
By evaluating PCI Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PCI Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PCI financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PCI Biotech Stock history
PCI Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PCI is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PCI Biotech Holding will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PCI Biotech stock prices may prove useful in developing a viable investing in PCI Biotech
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization technology platform. PCI Biotech Holding ASA was founded in 2000 and is headquartered in Oslo, Norway. PCI BIOTECH operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 11 people.
PCI Biotech Stock Technical Analysis
PCI Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PCI Biotech Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
PCI Biotech Holding cannot be verified against its exchange. Please verify the symbol is currently traded on Oslo Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PCI Biotech December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how PCI Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PCI Biotech shares will generate the highest return on investment. By undertsting and applying PCI Biotech stock market strength indicators, traders can identify PCI Biotech Holding entry and exit signals to maximize returns
PCI Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PCI Biotech's price direction in advance. Along with the technical and fundamental analysis of PCI Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PCI to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.17) | |||
Total Risk Alpha | (1.28) | |||
Treynor Ratio | (0.31) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.